Effects of Activity and Education Program on Patients With Chronic Hepatitis C Infection

NCT01572233 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2012-12-27

No results posted yet for this study

Summary

This 4-year project will be guided by a biobehavioral model for the study of exercise interventions in two phases with the purposes to :

1. explore the patients' physical activity preferences and develop doable activity lists during treatment period
2. examine the changes of health-related physical fitness component over interferon treatment
3. develop the Personalized Physical Activity and Psych-Education (PPAPE) Program and test its effects on decreasing fatigue, physical and psychological distress, and improving their health-related physical fitness and quality of life in patients with chronic hepatitis C receiving Interferon with Ribavirin Combination Therapy
4. evaluate the outcome of the PPAPE program on increasing adherence to therapy, the sustained virological response (SVR) in 24 weeks after the end of treatment, and the time-consuming for education program during intervention.

Conditions

  • Hepatitis C Virus Infection, Response to Therapy of

Interventions

BEHAVIORAL

Personalized Physical Activity and Psycho-Education (PPAPE) Program

1. Effects of Personalized Physical Activity and Psycho-Education Program on Patients with HCV infection 2. The third and fourth year, will be examine on the 12, 24, 36, and 48 weeks during the interferon treatment.

Sponsors & Collaborators

  • National Health Research Institutes, Taiwan

    collaborator OTHER
  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Shiow-ching Shun, PhD · National Taiwan University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2017-12-31
Completion
2018-06-30

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01572233 on ClinicalTrials.gov